We are Didecyl Dimethyl Ammonium Chloride CAS:7173-51-5 manufacturer and supplier in China, Pls send inquiry of to firstname.lastname@example.org of visit www.nbinno.com our official website should you have any interests
Synonym: N-Decyl-N,N-Dimethyldecan-1-Aminium Chloride
CAS Number: 7173-51-5
Chemical & Physical Properties
Density: 0.95 g/cm3 (20ºC)
Molecular Formula: C22H48ClN
Molecular Weight: 362.076
Exact Mass: 361.347534
Appearance : Colorless to pale yellow clear liquid
Active Assay : 80%±2%
PH : 5-9
Content of Free amine : ≤1.5%
Color (Pt-Co) : ≤150#
DDAC is widely used in oil field sterilization, medicine and hygiene, industrial circulating water sterilization and algae removal, oil field drilling and other fields. Its sterilization effect is better than the most widely used dodecyl dimethyl benzyl ammonium chloride. It can be used as a bactericide and bactericidal algicide in oilfield water injection and industrial circulating cooling water systems. When used as a bactericide for hard surface treatment, it can be used in combination with chlorine dioxide.
DDAC is a kind of wool moth agent, which can control insect diseases, and is used as a disinfectant and bactericide in medicine, health and civil use.
Package and Storage
180kgs/plastic drum. Should be stored in a sealed container in a cool and dry place. If the material freezes, it should be gently heated and stirred before use to ensure that the material is uniform.
Note: Avoid compatibility with anionic surfactants, dyes or auxiliaries.It is easy to absorb water and should be stored properly.
Market News:Over the duration of this study, investigators observed a 4.2% reduction in annualised absolute risk of cardiovascular death or heart failure hospitalisations compared to placebo. Ethyl 6-bromo-4-hydroxy-3-quinolinecarboxylate manufacturer.“This approval strengthens our product offering in the US and we look forward to the launch of generic Baclofen in due course.” 1-(4-methylphenyl)sulfonyl-4-phenylpiperidine-4-carboxylic acid supplier.Plexxikon filed a lawsuit against the pharma giant in 2017, alledging that Tafinlar, a rival to its melanoma drug Zelboraf that was brought to market in collaboration with Roche, has stepped on its intellectual property. The jury ruled in its favor, adding that the infringement is in fact willful. 5-piperidin-3-yloxy-1H-indazole producer.